Rovelito (atorvastatin/irbesartan)
/ Hanmi, Sanofi
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 14, 2019
Efficacy of a fixed dose combination of irbesartan and atorvastatin (Rovelito) in Korean adults with hypertension and hypercholesterolemia.
(PubMed, Drug Des Devel Ther)
- "Poor metabolic profiles were risk factors for poor treatment response and the reason for choosing Rovelito. Therapeutic lifestyle modification should still be underscored despite the 75% treatment success rate with Rovelito for both conditions."
Clinical • Journal
1 to 1
Of
1
Go to page
1